文献速递胸部肿瘤放疗放疗物理与技术

泛癌分析:Notch通路相关基因表达与肿瘤特异性及性别分层预后关联

Pan-cancer analysis of Notch pathway-linked gene expression identifies tumour-specific and sex-stratified prognostic associations.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-08-15

该研究利用TCGA和Kaplan-Meier Plotter公共数据集,分析九种癌症中14个Notch通路相关基因表达与总生存的关系。结果显示14个基因中13个至少在一种肿瘤中与OS显著相关,DLL3和JAG1呈跨癌种反复关联;性别分层分析发现额外预后关联,但多变量交互分析未一致支持性别为效应修饰因子;放疗后肺腺癌亚组中JAG1高表达与较差OS相关,但未在调整的泛癌RT验证队列中证实。

要点

  • 14个Notch通路基因中13个至少在一种肿瘤中与OS显著相关。
  • DLL3和JAG1在多种癌症中反复出现预后关联。
  • 性别分层有额外关联,但交互分析未一致支持性别效应修饰。

核心结论

  • 这项探索性泛癌分析发现多个Notch通路相关基因表达与OS存在关联,其中DLL3和JAG1呈反复关联。
  • 性别分层分析的差异及放疗后肺腺癌亚组结果需在独立队列中进一步研究。

研究设计与样本

  • 研究分析九种癌症患者的基因表达与临床数据,数据来自TCGA和Kaplan-Meier Plotter公共数据集。
  • 采用Kaplan-Meier生存分析评估14个Notch通路相关基因表达与OS的关联。
  • 代表性发现进一步用多变量Cox比例风险模型评估,纳入临床协变量和基因表达×性别交互项。

主要发现

  • 九种癌症中,14个Notch通路相关基因里有13个至少在一种肿瘤类型中与OS显著相关。
  • DLL3和JAG1在多种癌症中反复出现关联,DLL3高表达更常与较差OS相关。
  • 性别分层分析识别出额外预后关联,但多变量交互分析未一致支持生物学性别为效应修饰因子。
  • 在放疗后肺腺癌亚组中,JAG1高表达与较差OS相关,但该关联未在调整的泛癌RT验证队列中证实。

临床怎么用

  • DLL3和JAG1的表达可能作为跨癌种预后相关标志物供进一步研究,但当前证据尚不足以指导临床决策。
  • 性别分层和放疗相关亚组结果仅为探索性,需独立队列验证后再考虑用于患者分层。

局限性

  • 研究为探索性分析,结论需在独立队列中进一步验证。
  • 性别分层分析的额外关联未在多变量交互分析中一致支持性别为效应修饰因子。
  • 放疗后肺腺癌亚组的JAG1关联未在调整的泛癌RT验证队列中证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Notch signalling pathway regulates cell fate, proliferation, and differentiation and consists of receptors (Notch1-4), ligands (JAG1-2, DLL1, DLL3-4), and downstream targets. Altered expression of Notch pathway-linked genes has been reported in multiple cancers, although their associations with survival may vary according to tumour type. Their relationship with biological sex and radiotherapy (RT) has been less extensively explored. PURPOSE: To explore associations between Notch pathway-linked gene expression and overall survival (OS) across multiple cancer types, and to examine whether these associations differ by biological sex or in an RT-treated lung cancer subgroup. METHODOLOGY: Gene expression and clinical data from patients across nine cancer types were analysed using publicly available datasets derived from The Cancer Genome Atlas (TCGA) and the Kaplan-Meier Plotter platform. Associations between the expression of 14 Notch pathway-linked genes and OS were evaluated using Kaplan-Meier survival analyses. Representative findings were further evaluated using multivariable Cox proportional hazards models incorporating clinical covariates and gene expression × sex interaction terms. MAIN FINDINGS: Across nine cancer types, 13 of the 14 Notch pathway-linked genes were significantly associated with OS in at least one tumour type. DLL3 and JAG1 demonstrated recurrent associations across multiple cancers, with higher DLL3 expression more frequently associated with poorer OS. Sex-stratified analyses identified additional prognostic associations; however, multivariable interaction analyses did not consistently support biological sex as an effect modifier. In the RT-treated lung adenocarcinoma subgroup, higher JAG1 expression was associated with poorer OS, although this association was not confirmed in an adjusted pan-cancer RT validation cohort. CONCLUSION: This exploratory pan-cancer analysis identified associations between the expression of several Notch pathway-linked genes and OS, including recurrent associations involving DLL3 and JAG1. Differences observed in sex-stratified analyses and the RT-treated lung adenocarcinoma subgroup warrant further investigation in independent cohorts.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. O'Hea H, Bourbonne V, Marignol L, et al. Pan-cancer analysis of Notch pathway-linked gene expression identifies tumour-specific and sex-stratified prognostic associations. Clin Transl Radiat Oncol. 2026. PMID: 42668613. doi:10.1016/j.ctro.2026.101268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。